SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Traders are actively debating a proposal to issue a $5,000 dividend to every U.S. adult if Republicans win the upcoming midterm elections, with widespread skepticism regarding the promise's feasibility and its potential impact on national debt and inflation. Discussion is heavily polarized, featuring accusations of vote-buying and economic mismanagement alongside political posturing.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The SPY is trending as retail traders react to macroeconomic pressures, including rising bond yields near 5% and climbing crude oil prices, alongside skepticism regarding a proposed $5,000 midterm dividend payment. The community remains divided, with many debating the impact of inflationary data and potential Federal Reserve rate hikes, while some market participants express concern over the sustainability of current equity valuations.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending amid broader market caution driven by concerns over surging Treasury yields and high oil prices. Traders are focused on upcoming inflation data and economic reports, while debate continues regarding potential policy interventions.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending due to rising oil prices fueled by escalating geopolitical tensions in the Middle East, particularly reports of strikes on oil tankers and tankers in the Strait of Hormuz. Traders are actively debating the sustainability of the rally, with many expressing concern over the economic impact of elevated energy costs while some remain bullish on further price increases.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

The iShares 20+ Year Treasury Bond ETF (TLT) is trending as traders debate the impact of rising long-term Treasury yields, fueled by concerns over persistent inflation, high energy prices, and geopolitical tensions. Market participants are divided on the efficacy of government interventions, such as the Treasury's expanded bond buyback program, with many skeptical that these measures can sustainably lower yields given the current macroeconomic backdrop and federal debt levels.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing intense selling pressure following a Morgan Stanley downgrade to Underweight with a low price target, fueling concerns over the company's earnings recovery and China revenue. The community remains deeply divided, with many traders betting on further downside while others argue the stock is oversold and view it as a potential long-term value opportunity.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Market participants are focused on the impact of ongoing Middle East geopolitical tensions and supply disruptions in the Strait of Hormuz on global LNG availability. While some traders view the stock as undervalued given strong EBITDA growth and increased production potential, others express frustration over institutional manipulation and persistent price suppression.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following the unveiling of its new foldable iPhone Duo, with the community sharply divided over the device's $1,999 starting price and its perceived lack of innovation. While some traders view the foldable form factor as a potential revenue growth catalyst and a successful hardware pivot for the new CEO, others argue the price is excessive, the innovation is derivative of competitors, and the device lacks clear utility.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line is trending due to trader frustration over consistent share price declines, which many attribute to algorithmic manipulation and sensitivity to rising oil prices. While some investors see a long-term recovery opportunity following recent insider and institutional buying, others are expressing concern over the company's high debt load and persistent downward price pressure.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing volatility as traders debate whether it can sustain its current range and reclaim the 80k level. Sentiment remains split, with bulls eyeing a potential breakout on technical signals and liquidity events, while bears point to macro headwinds, including inflation concerns and geopolitical instability.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ALT  Everyone keeps asking about timing like there’s some tell in the tape or meeting timing giveaways. There isn’t.

My thesis on $ALT timing isn’t based on hopium. It’s based on historical facts from recent MASH deals like $AKRO  and $ETNB. Go back and look at the charts before their deals.

Price action didn’t signal it.
Options flow didn’t signal it.
Volume didn’t signal it.
Short interest didn’t signal it.
Conference meetings didn’t signal it.

Nothing in the public market telegraphed the announcement. Then boom. Out of nowhere. After the fact, when the companies released board minutes and transaction details, what did we learn? They had been in discussions with 8–10 big pharma players for 12–24 months prior to the announcement. Active dialogue. Ongoing engagement. Multiple counterparties. All while retail was staring at daily candles trying to decode “signals.” There was no incubation period visible to the public. The only consistent pattern? Deals occurred during or around Phase 3 execution. That’s the key. So when I frame a partnership or acquisition thesis for Alt, I’m not guessing dates. I’m anchoring to precedent. MASH assets with strong Phase 2 data enter Phase 3, strategic engagement intensifies, and at some point during that window a transaction materializes. Could it be earlier? Yes. Could it be later? Yes. But history shows you won’t see it coming in the tape. It just happens. That’s why I focus on fundamentals, design, differentiation, and strategic positioning, NOT daily noise. Timing is unknown to us. Precedent is not.

kevin conley

Blank Stocker

NoahVN

MJ Candlec

Scott

Jim Patrick

Patrick R.

Bull

Rhung

Jan Paul Beahm

Kevin Day

Stock Australopithecus

NappyDadDude

Chop1182

Robert Slovenz

Layne_Thomas_Staley

LORRAINE PEARSON

Jim Reader

thaines1

Romanovskie

Michael Moore

Biotech And Real Estate

tanzil

GoTime

Rich79

julsa

Joe Williams

$GALT @Expharmaguy would like all of us to check out this post.

StockTwits For Android 

"Schuuultz!"

$ALT @PashaGainz agreed.  Show me the P3 plan and projected costs.  Show me an AA plan.  We know the science is excellent.  Potential partners know the science is excellent.  Quality weight loss, with AI assist biopsy analysis and NITs.

This drug is gold.  For me…

StockTwits for iOS

BigElvis_GTown

$ALT Remind me again why anyone believes ANYTHING remotely related to $ALT from this guy (@PashaGainz). 
 
Pashy, can you help us understand your statement?  Maybe show us where we can find that 48W MASH and fibrosis data?   
 
(For those that don&#39;t know, MASH and fibrosis were note measured or an endpoint at 48W). 
 
Pashy&#39;s quote: 
&quot;$ALT just hit stat sig in both MASH and fibrosis at 48 week phase 2!!!  BIC tolerability!  Accelerated approval coming!!!&quot; 
 
What a joke. 
 
Typical $ALT.

StockTwits Web

The Legendary Mayor

$ALT @PashaGainz And let&#39;s take a more realistic approach.  What do you see happening to $ALT Share Price if they GIA?  Also, you realize current projections have MASH P3 enrollment not being completed until July, 2029.  Are you willing to hold $ALT until then?

$ALT this is also the same clown who&#39;s posted for over 2 years that a buyout and partnership is &quot;soon&quot;, &quot;weeks away&quot;, &quot;big things coming soon&quot;.  How could you even take anything clowns like this post seriously.

Noname

Altimmune Inc

Akero Therapeutics Inc

89bio Inc

  Everyone keeps asking about timing like there’s some tell in the tape or meeting timing giveaways. There isn’t.

My thesis on 

 timing isn’t based on hopium. It’s based on historical facts from recent MASH deals like 

. Go back and look at the charts before their deals.

Price action didn’t signal it.
Options flow didn’t signal it.
Volume didn’t signal it.
Short interest didn’t signal it.
Conference meetings didn’t signal it.

Nothing in the public market telegraphed the announcement. Then boom. Out of nowhere. After the fact, when the companies released board minutes and transaction details, what did we learn? They had been in discussions with 8–10 big pharma players for 12–24 months prior to the announcement. Active dialogue. Ongoing engagement. Multiple counterparties. All while retail was staring at daily candles trying to decode “signals.” There was no incubation period visible to the public. The only consistent pattern? Deals occurred during or around Phase 3 execution. That’s the key. So when I frame a partnership or acquisition thesis for Alt, I’m not guessing dates. I’m anchoring to precedent. MASH assets with strong Phase 2 data enter Phase 3, strategic engagement intensifies, and at some point during that window a transaction materializes. Could it be earlier? Yes. Could it be later? Yes. But history shows you won’t see it coming in the tape. It just happens. That’s why I focus on fundamentals, design, differentiation, and strategic positioning, NOT daily noise. Timing is unknown to us. Precedent is not.

PashaGainz

@PashaGainz agreed.. these companies have become very good at staying quiet

Ty pasha :)

Ilovemuffins1

Mary OReilly

Bob Addair

Brian P.

Corpkcots

 agreed.. these companies have become very good at staying quiet

Ty pasha :)

Go Bucks

Robert hardy

Austin

@PashaGainz Excellent presentation, congratulations and thank you💯👌💯💥💥💥

 Excellent presentation, congratulations and thank you💯👌💯💥💥💥

@PashaGainz You forgot to mention $ALT has one thing that $AKRO and $ETNB didn&#39;t...a FAILED drug for one of their MASH P2b trial Primary Endpoints.   
 
So yes, you&#39;re full of hopium.  Always have been.  And this isn&#39;t conviction, this is trying to save face.   
 
Little secret, no one missed you when you were gone.

 didn't...a FAILED drug for one of their MASH P2b trial Primary Endpoints.   
 
So yes, you're full of hopium.  Always have been.  And this isn't conviction, this is trying to save face.   
 
Little secret, no one missed you when you were gone.

@PashaGainz Oh yeah, for your argument, they also didn&#39;t have a CEO change in the middle of the time period you referenced, $ALT did.

 Oh yeah, for your argument, they also didn't have a CEO change in the middle of the time period you referenced, 

@PashaGainz didn&#39;t have their CMO walk in the middle of the time period you referenced and in the middle of the trial, $ALT did.

 didn't have their CMO walk in the middle of the time period you referenced and in the middle of the trial, 